Objective: Frailty is associated with adverse events, length of stay, and nonhome discharge after vascular surgery. Frailty measures based on walking-based tests may be impractical or invalid for patients with walking impairment from symptoms or sequelae of vascular disease. We hypothesized that grip strength is associated with frailty, comorbidity, and cardiac risk among patients with vascular disease.
Frailty is associated with increased risk of postoperative complications, increased length of hospitalization, and nursing facility discharge after vascular surgery. [1] [2] [3] [4] Approximately 10% to 20% of individuals older than 65 years are considered frail, 5, 6 with an even higher percentage of individuals, up to 37%, considered prefrail. 7 A 101% increase in vascular surgery patients aged 65 to 84 years is projected by 2040, 8 underscoring the importance of identifying frailty and incorporating this variable into preoperative risk assessment and procedure planning. Despite the relevance of frailty to patients with vascular disease, there is no widely accepted "gold standard" measure, and assessment in this population is often problematic. Because many validated frailty measures use walkingbased tests (such as gait speed, 9 timed up-and-go, 10 and metabolic equivalents 11 ), they may be impractical or invalid for patients with walking impairment from symptoms or sequelae of vascular disease (such as symptomatic peripheral artery disease [PAD] or previous amputation).
Grip strength has also been used for frailty assessment among the elderly, [12] [13] [14] although use within disease-specific populations (such as clinical cardiovascular disease) has not been rigorously validated. Grip strength can be obtained easily and inexpensively in clinical environments, making this measure potentially useful as an alternative to walking-based frailty assessment for patients being evaluated for vascular surgery (and other populations in which disease-specific factors may impair walking ability). Population-specific validity of grip strength as a stand-alone surrogate measure of frailty among patients with vascular disease, however, has not been extensively described. We hypothesized that grip strength is associated with measures of frailty, comorbidity, and cardiac risk among patients with vascular disease. To test these hypotheses, we measured grip strength among patients presenting to outpatient vascular surgery and vascular medicine clinics and explored associations with other measures of frailty, comorbidity, and cardiovascular risk.
METHODS
Study design and participants. Adult patients were recruited from an outpatient vascular clinic (staffed by physicians and nurse practitioners specializing in vascular surgery and vascular medicine) during routine visits at an academic medical center during a 9-month period (August-April 2016). Inclusion criteria were ability to provide informed consent and clinical diagnosis of PAD, abdominal aortic aneurysm (AAA), or carotid artery stenosis. Exclusion criteria included known factors with potential to affect dominant hand strength or function (including history of upper extremity paralysis, stroke, arthritis, or recent ipsilateral upper extremity trauma or surgery). Participant recruitment was based on the research assistant's availability and therefore did not include all consecutive patients who had clinic visits during the study period. This study was approved by the Wake Forest University School of Medicine Institutional Review Board, and informed consent was obtained from participants. This prospective, cross-sectional study was conducted with future plans for follow-up longitudinal analyses of the same cohort evaluating adverse perioperative events, adverse cardiovascular events, and longterm mortality as outcomes.
Grip strength measurement. Participants underwent dominant hand grip strength measurement using a calibrated hydraulic hand dynamometer (Jamar Hand Dynamometer [Performance Health, Warrenville, Ill]; Fig 1) after agreeing to participate. Grip strength measurements were obtained by a trained research assistant during vital sign measurement; measurements were obtained only during this part of the clinic intake process to avoid prolonged wait times or other negative impacts on visits. Grip strength in kilograms was measured using a standardized protocol; participants were seated with the ipsilateral shoulder adducted and neutrally rotated, the elbow flexed to 90 degrees, and the forearm and wrist neutrally positioned. After zeroing the peak-hold needle, a single maximum grip strength measurement was obtained and recorded to the nearest kilogram.
Clinical and demographic data. Additional variables collected from the electronic medical record included age, race, gender, and comorbid conditions (history of myocardial infarction, ischemic heart disease, congestive heart failure, cerebrovascular disease including stroke or transient ischemic attack, chronic obstructive pulmonary 
Recommendation:
The results of this study suggest that frailty is highly prevalent among patients with vascular disease and that grip strength measurement is potentially useful as a screening tool in this population.
disease, connective tissue disease, ulcer disease, liver disease, kidney disease, diabetes including hemiplegia, and smoking). Laboratory values collected from the electronic medical record included serum concentrations of hemoglobin, creatinine, blood urea nitrogen, and albumin when available within 6 months of grip measurement. Data were collected and managed using the secure online data capture tool REDCap. 15 Comorbidity, cardiovascular risk, and sarcopenia assessment. Associations between grip strength and three risk measures were evaluated: the Charlson Comorbidity Index (CCI), 16 the Revised Cardiac Risk Index (RCRI), 17 and sarcopenia based on total psoas area 18, 19 measured from cross-sectional imaging. The CCI was used to assess comorbidity. This measure is based on 19 weighted candidate health conditions and is predictive of 1-year mortality among hospitalized adults. 16 The RCRI is a validated multivariable index used to assess perioperative risk of major cardiac complications (including myocardial infarction, pulmonary edema, ventricular fibrillation or primary cardiac arrest, and complete heart block). The RCRI is useful for predicting risk of major adverse cardiac events in patients undergoing noncardiac surgery and has been recommended for preoperative risk evaluation. 20 The RCRI is also used for assessing cardiac risk by cardiology consultants and by anesthesiologists in the preoperative clinic at our institution.
Components of the RCRI include history of ischemic heart disease, history of congestive heart failure, history of cerebrovascular disease, preoperative treatment with insulin, and preoperative serum creatinine concentration >2 mg/dL. 17 Patients lacking serum creatinine measurement within 6 months of grip strength measurement were excluded from RCRI calculation and analysis. All participants were evaluated from the perspective of high-risk surgery for the surgical risk component of the RCRI and therefore given 1 point for this attribute, regardless of their diagnosis or whether the clinic visit was related to a recent or anticipated procedure. The high-risk surgery perspective was selected because frailty would be most likely to have an impact on decisionmaking under these circumstances (conversely, frailty might be less relevant to patient selection or technical planning for lower risk procedures). Within multivariable models, the RCRI score was evaluated as the sum of RCRI components for each patient. Total psoas area has demonstrated validity as a surrogate measure of sarcopenia and frailty and is associated with mortality after elective AAA repair. 17, 19 This variable was calculated in square centimeters at the level of the fourth lumbar (L4) vertebral body in those patients with cross-sectional computed tomography imaging within 90 days of grip strength measurement. A defined protocol for psoas measurement was used by two independent reviewers (T.E.R. and R.U.). 17 First, the superior aspect of the fourth lumbar vertebral body was identified from a three-dimensional sagittal reconstruction view. Scout mode was then used to identify the corresponding cross-sectional image in the axial view. Bilateral psoas circumferences were then defined at this level, and their combined cross-sectional area was calculated using a proprietary radiographic image analysis program (Philips iSite PACS v3.6; Philips Healthcare Informatics, Foster City, Calif). Mean of the total psoas areas calculated from both reviewers' measurements was used for statistical analysis to minimize observer-related variance.
Statistical analysis. Descriptive statistics are displayed as mean 6 standard deviation (SD) for continuous variables and frequency (percentage) for categorical variables. For patients with a history of more than one vascular disease diagnosis, the primary diagnosis for the clinic visit when grip strength was measured was used for analysis. Associations between grip strength, cardiovascular risk, and sarcopenia were evaluated using linear regression models adjusted for other variables. Participants were categorized as frail if their grip strength was below the 20th percentile of a community-dwelling population adjusted for gender and body mass index (BMI) from the Cardiovascular Health Study previously described by Fried et al 21 (Table I) . Associations between frailty, comorbidity, and cardiovascular risk were evaluated using logistic regression models with frailty as a dichotomous outcome. Diagnosis-specific comparisons of psoas diameters were performed using least squares means from multivariable linear regression models. For both linear and logistic regression analysis, multivariable models were used to adjust for potential confounders including age, gender, height, and comorbidities. All statistical analyses were performed using SAS 9.4 software (SAS Institute, Cary, NC). A P value < .05 was considered significant. 
RESULTS
During the study period, 601 participants were screened; 311 (52%) were enrolled and underwent grip strength measurement during clinic visits related to PAD (53.4%), carotid artery stenosis (37.3%), and AAA (28.0%). The most common reasons for nonparticipation were previous history of upper extremity surgery (most commonly hemodialysis access) and lack of the research assistant's availability during vital sign measurement. Descriptive statistics are shown in Table II ; 106 participants (34.1%) were women, and 284 (91.3%) were right handed. The mean age of the participants was 69.1 6 9.5 years; mean BMI was 27.9 6 5.9 kg/m 2 . Ninety-nine patients (31.8%) had history of ischemic heart disease, and 274 (88.1%) were current or former smokers. Mean grip strength was 38.6 6 9.3 kg for men vs 19.5 6 5.5 kg for women. Based on the BMI-and gender-adjusted criteria described by Fried et al, 21 86 patients (27.7%)
were categorized as frail. Frail participants were older than nonfrail participants (mean age, 71.4 6 10.3 years vs 68.3 6 9.0 years; P ¼ .010). Women had a higher prevalence of frailty than men (55.8% vs 44.2%; P < .0001). PAD was the most common primary diagnosis for clinic visits among the 86 frail patients (54.7%), followed by carotid stenosis (38.4%) and AAA (27.9%). No significant association between frailty and primary visit-related diagnosis was observed (Table II) . Table III summarizes data completeness among study participants. All 311 participants underwent both grip strength measurement and CCI calculation. The mean CCI was 5.6 6 2.3 (Table IV) , and scores were higher in frail vs nonfrail participants (6.4 6 2.2 vs 5.2 6 2.2; P < .0001). CCI was significantly associated with frailty in a simple logistic regression model (odds ratio [OR], 1.72; 95% confidence interval [CI], 1.33-3.23; P < .0001), and this association remained significant after adjusting for gender, age, height, and PAD (OR, 1.86; 95% CI, 1.34-2.57; P < .0001; Table V) . A linear association between CCI and grip strength was also observed. Each SD increase (2.3 units) in CCI was associated with a 2.3 kg decrease in grip strength (R 2 ¼ 3%; P ¼ .001; Fig 2) . This weak but highly significant correlation was also observed in the multivariable linear model adjusting for age and gender, in which each SD increase in CCI was associated with a 2.1 kg decrease in grip strength (P < .0001). There were 217 patients (69.8%) who had adequate data for RCRI calculation; 116 (53.5%) were defined as RCRI class II, 74 (34.1%) as RCRI class III, and 27 (12.4%) as RCRI class IV. Twenty-six patients (40.0%) with class II RCRI were frail compared with 29 patients (44.6%) with class III and 10 patients (15.4%) with class IV. The average number of RCRI components for frail patients was higher than that for nonfrail patients (mean 6 SD, 1.8 6 0.8 for frail; 1.5 6 0.7 for nonfrail; P ¼ .018; Table V) .
A multivariable logistic frailty model that included total psoas area, CCI, and RCRI as covariates was used to evaluate a subgroup of 82 participants (26.3%) with complete data for calculation of all three outcomes. Directions and magnitudes of ORs in this multivariable model were similar to those observed in pairwise analyses, but the associations were no longer significant after adjustment for age, gender, height, and PAD diagnosis (Table V) .
DISCUSSION
Frailty is a characteristic that many clinicians can recognize but may have difficulty quantifying objectively. Frailty, as defined by Fried et al, 21 is "a biologic syndrome of decreased reserve and resistance to stressors resulting from cumulative declines across multiple physiologic systems and causing vulnerability to adverse outcomes." This concept, initially established and widely used by specialists in geriatric medicine, is also relevant to patients with vascular disease being considered for operative interventions. Accurate identification of decreased reserve and increased vulnerability to complications might inform treatment or patient selection, enabling patients and providers to avoid (or at least to minimize) stressors and related risks. Frailty detection might also provide opportunities for prehabilitation through exercise, nutritional, and behavioral interventions to better prepare patients and perhaps to decrease risk when procedures can be delayed but not avoided. With these considerations in mind, we used grip strength to characterize frailty prevalence among patients being treated for vascular disease and to explore associations with established measures of sarcopenia, comorbidity, and cardiovascular risk. Results of this analysis suggest that frailty is highly prevalent among patients with clinically significant vascular disease and that grip strength measurement may be a practically useful risk assessment in this population of patients. As a test that is easily integrated into the process of outpatient clinic visits with results that are immediately available at the time of treatment decision-making, grip strength measurement has potential advantages over more comprehensive approaches that may be challenging to implement in clinical settings where resources (including time) may be limited. Frailty assessment has been championed as a routine component of preoperative decision-making for vascular surgery by Kraiss et al. 22 These authors compared and contrasted use of the phenotype approach to frailty assessment (exemplified by the methods described by ). These approaches are generally regarded as complementary rather than mutually exclusive. 24 Phenotype methods may have advantages in terms of simplicity and ease of administration, whereas accumulated deficits models offer more comprehensive and multidimensional assessments at the cost of increased time (potentially on the part of a clinician). 22 Our analysis sought to evaluate the utility of further streamlining frailty assessment through use of grip strength, an individual component test included in many phenotype approaches. Utility of grip strength as a stand-alone screening tool in patients with established vascular disease has not been thoroughly evaluated, and interest in use of this individual measure arose from concerns about validity of walking-based tests in patients with vascular disease. Grip strength may have specific applicability for frailty assessment in patients with symptomatic PAD (including those with previous amputation), particularly if disease-related walking impairment confounds interpretation of walking-based measures (or makes them impossible to obtain). Compared with age-and gendermatched controls, patients with vascular disease have been observed to have both weaker grip strength and higher Edmonton Frailty Scale scores. 4 Utility of individual phenotype components as key frailty indicators (including grip strength) has been demonstrated previously in other populations of patients. 13, 25 Frailty prevalence among populations defined by age, comorbid conditions, and surgical procedures has been characterized previously by others. Revenig et al 13 prospectively evaluated frailty among patients and sending for major general, oncologic, and urologic procedures using the Hopkins Frailty Score and compared these results with measures of surgical risk that included the American Society of Anesthesiologists scale, Eastern Cooperative Oncology Group performance status, and CCI. Based on the Hopkins Frailty Score (which includes both grip strength and walking speed as components), these authors reported a 3.7% prevalence of frailty, whereas 23% were categorized as intermediately frail. They also observed increased risk for perioperative complications among patients categorized as either intermediately frail or frail. Associations between frailty and risk of perioperative adverse events (including complications, readmission, and long-term mortality) have also been observed in surgical cohorts defined by age, abdominal operations, colorectal operations, and cardiac surgery. [26] [27] [28] [29] Arya et al 30 identified a frailty prevalence of 37% among patients undergoing vascular procedures within the American College of Surgeons National Surgery Quality Improvement Program data file. This study defined frailty using the Canadian Study of Health and Aging modified Frailty Index, which includes comorbid conditions (history of diabetes, pulmonary disease, congestive heart failure, myocardial infarction, angina, hypertension, transient ischemic attack, or stroke), impaired sensorium, and functional status. These authors also observed associations between frailty and increased risk of both perioperative complications and nonhome discharge in the study. The slightly lower (although comparable) frailty prevalence in our analysis may reflect differences in sensitivity of grip strength measurement vs retrospective use of the modified Frailty Index as screening tools. Higher prevalence of frailty in vascular patients compared with populations defined by age, other comorbid conditions, or surgical procedures may reflect differences in disease-specific prevalence or selection bias (our analysis included patients regardless of whether they were scheduled for surgery). Medical patients with frail phenotype are also at higher risk of disability, hospitalization, morbidity, and mortality. 14, 21, 31 Frail phenotype is also independently associated with cardiovascular disease and female gender. 21, 32 Although frailty may not be a modifiable risk factor, improved screening may facilitate individualized treatment selection, counseling, and resource expectations. Based on the results of this analysis, we plan to implement routine grip strength measurement during clinic intake for new patients as a larger scale quality improvement initiative, with plans to re-evaluate approaches to perioperative testing, prehabilitation, and discharge planning on the basis of the results of ongoing follow-up studies.
An association between total psoas diameter and mortality after open AAA repair has been reported previously by Lee et al. 19 These authors evaluated total psoas area as a continuous variable in a multivariable Cox model of mortality adjusted for age, gender, and comorbid conditions. Associations between total psoas diameter and mortality have also been observed after liver transplantation. 33 Abdominal imaging was available for only 54% of patients undergoing surgical AAA repair screened by Lee et al and only 88 of 311 patients (28%) of our cohort that also included patients with PAD and carotid stenosis. The trend toward an association between PAD and lower total psoas area observed in this study is the first reported to our knowledge, warrants confirmation in a larger sample of patients, and suggests that patients with PAD may warrant diagnosis-specific approaches to morphomic analysis. Although a direct correlation between grip strength and mortality among patients with vascular disease remains to be proved (and is a followup analysis planned for this participant cohort), the results of this study suggest that grip strength measurement could be used to expand screening for frailty and sarcopenia, extending noninvasive assessment to patients who have disease-related walking impairment or lack cross-sectional abdominal imaging. Several limitations of this study warrant specific mention. First, although grip strength was prospectively measured, clinical data were collected from the medical record. Because laboratory testing and imaging were obtained only as part of routine clinical care, these data were not available for all patients, decreasing the number of participants eligible for subgroup analyses of both RCRI and psoas area. Second, we obtained a single grip strength measurement from each participant instead of using the mean of several measurements as described by others. 21 This approach was deliberately chosen to evaluate grip strength measurement as an assessment that might be easily implemented in a clinical setting, but it may have had an impact on the precision and significance of our results through observer-related variance or lack of patient learning effects. Third, clinical outcomes in this analysis were limited to other indexes of risk and mortality (rather than to events). To further test and validate the clinical utility of grip strength as a risk screening tool, we have initiated ongoing longitudinal follow-up studies of this cohort of patients with anticipated analyses of adverse events and survival. Fourth, our consideration of all patients from the perspective of a high-risk procedure (which we believed was the scenario in which identification of frailty would be most likely to have an impact on decision-making) affected RCRI calculation and did not allow comparisons with lower risk scenarios. Finally, the outcomes were chosen on the basis of practical considerations (such as clinical use for risk assessment at our institution) and to allow comparisons with other populations. These measures, however, were not specifically developed for use in patients with vascular disease, and the results therefore are not generalizable to alternative, vascular-specific measures. These limitations aside, this study provides a useful evaluation of frailty prevalence based on grip strength among patients with vascular disease and establishes a rationale for further exploration of this measure as a practical risk assessment tool.
CONCLUSIONS
Frailty is highly prevalent among patients with vascular disease and is associated with comorbidity, cardiac risk, and sarcopenia in this population. Grip strength measurement may have utility as a simple and inexpensive risk screening tool that is easily implemented in ambulatory clinics, avoids the need for imaging, and overcomes possible limitations of walking-based measures. Lower mean psoas diameters among patients with PAD may warrant specific approaches to morphomic analysis, including assessment of sarcopenia.
